{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T15:24:25Z","timestamp":1767713065560},"reference-count":31,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,5]]},"DOI":"10.7759\/cureus.17732","type":"journal-article","created":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T18:02:56Z","timestamp":1630951376000},"source":"Crossref","is-referenced-by-count":4,"title":["Metabolic Acidosis in Leukemia"],"prefix":"10.7759","author":[{"given":"Jaskamal","family":"Padda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khizer","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varsha","family":"Kakani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayden Charlene","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gutteridge","family":"Jean-Charles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBACON estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBACON estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-49. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel RL","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021, 71:7-33. 10.3322\/caac.21654","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1019034","article-title":"Severe metabolic acidemia in a patient with aleukemic leukemia","volume":"2018","author":"Ghrewati M","year":"2018","unstructured":"Ghrewati M, Manji F, Modi V, Chandran C, Maroules M. Severe metabolic acidemia in a patient with aleukemic leukemia. Case Rep Nephrol. 2018, 2018:1019034. 10.1155\/2018\/1019034","journal-title":"Case Rep Nephrol"},{"key":"ref4","unstructured":"Leukemia. (2021). Accessed. April 15 2021: https:\/\/www.mayoclinic.org\/diseases-conditions\/leukemia\/symptoms-causes\/syc-20374373."},{"key":"ref5","unstructured":"Leukemia. (2019). Accessed. April 15 2021: https:\/\/my.clevelandclinic.org\/health\/diseases\/4365-leukemia."},{"key":"ref6","unstructured":"Leukemia. (2019). Accessed. April 16 2021: https:\/\/www.webmd.com\/cancer\/lymphoma\/understanding-leukemia-basics."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1158\/jcr.1925.148","article-title":"The metabolism of carcinoma cells","volume":"9","author":"Warburg O","year":"1925","unstructured":"Warburg O. The metabolism of carcinoma cells. J Cancer Res. 1925, 9:148-163. 10.1158\/jcr.1925.148","journal-title":"J Cancer Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg effect: how does it benefit cancer cells?","volume":"41","author":"Liberti MV","year":"2016","unstructured":"Liberti MV, Locasale JW. The Warburg effect: how does it benefit cancer cells?. Trends Biochem Sci. 2016, 41:211-8. 10.1016\/j.tibs.2015.12.001","journal-title":"Trends Biochem Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4161\/23723556.2014.981988","article-title":"Targeting the Warburg effect for leukemia therapy: magnitude matters","volume":"2","author":"Wang YH","year":"2015","unstructured":"Wang YH, Scadden DT. Targeting the Warburg effect for leukemia therapy: magnitude matters. Mol Cell Oncol. 2015, 2:e981988. 10.4161\/23723556.2014.981988","journal-title":"Mol Cell Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-0555","article-title":"The warburg effect in leukemia-stroma cocultures is mediated by mitochondrial uncoupling associated with uncoupling protein 2 activation","volume":"68","author":"Samudio I","year":"2008","unstructured":"Samudio I, Fiegl M, McQueen T, Clise-Dwyer K, Andreeff M. The warburg effect in leukemia-stroma cocultures is mediated by mitochondrial uncoupling associated with uncoupling protein 2 activation. Cancer Res. 2008, 68:5198-205. 10.1158\/0008-5472.CAN-08-0555","journal-title":"Cancer Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/BF01874168","article-title":"History of the Pasteur effect and its pathobiology","volume":"5","author":"Racker E","year":"1974","unstructured":"Racker E. History of the Pasteur effect and its pathobiology. Mol Cell Biochem. 1974, 5:17-23. 10.1007\/BF01874168","journal-title":"Mol Cell Biochem"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108690","article-title":"Cancer cells change their glucose metabolism to overcome increased ROS: one step from cancer cell to cancer stem cell?","volume":"112","author":"Ghanbari Movahed Z","year":"2019","unstructured":"Ghanbari Movahed Z, Rastegari-Pouyani M, Mohammadi MH, Mansouri K. Cancer cells change their glucose metabolism to overcome increased ROS: one step from cancer cell to cancer stem cell?. Biomed Pharmacother. 2019, 112:108690. 10.1016\/j.biopha.2019.108690","journal-title":"Biomed Pharmacother"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-018-0088-y","article-title":"Crosstalk between the Warburg effect, redox regulation and autophagy induction in tumourigenesis","volume":"23","author":"Gwangwa MV","year":"2018","unstructured":"Gwangwa MV, Joubert AM, Visagie MH. Crosstalk between the Warburg effect, redox regulation and autophagy induction in tumourigenesis. Cell Mol Biol Lett. 2018, 23:20. 10.1186\/s11658-018-0088-y","journal-title":"Cell Mol Biol Lett"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/1177271918755391","article-title":"Reactive oxygen species: a key constituent in cancer survival","volume":"13","author":"Kumari S","year":"2018","unstructured":"Kumari S, Badana AK, G MM, G S, Malla R. Reactive oxygen species: a key constituent in cancer survival. Biomark Insights. 2018, 13:1177271918755391. 10.1177\/1177271918755391","journal-title":"Biomark Insights"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2929","article-title":"Glycolytic metabolism influences global chromatin structure","volume":"6","author":"Liu XS","year":"2015","unstructured":"Liu XS, Little JB, Yuan ZM. Glycolytic metabolism influences global chromatin structure. Oncotarget. 2015, 6:4214-25. 10.18632\/oncotarget.2929","journal-title":"Oncotarget"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden MG","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009, 324:1029-33. 10.1126\/science.1160809","journal-title":"Science"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/2049-3002-2-7","article-title":"Separation of metabolic supply and demand: aerobic glycolysis as a normal physiological response to fluctuating energetic demands in the membrane","volume":"2","author":"Epstein T","year":"2014","unstructured":"Epstein T, Xu L, Gillies RJ, Gatenby RA. Separation of metabolic supply and demand: aerobic glycolysis as a normal physiological response to fluctuating energetic demands in the membrane. Cancer Metab. 2014, 2:7. 10.1186\/2049-3002-2-7","journal-title":"Cancer Metab"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers3010408","article-title":"Tumor acidity as evolutionary spite","volume":"3","author":"Alfarouk KO","year":"2011","unstructured":"Alfarouk KO, Muddathir AK, Shayoub ME. Tumor acidity as evolutionary spite. Cancers (Basel). 2011, 3:408-14. 10.3390\/cancers3010408","journal-title":"Cancers (Basel)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-2796","article-title":"Acidity generated by the tumor microenvironment drives local invasion","volume":"73","author":"Estrella V","year":"2013","unstructured":"Estrella V, Chen T, Lloyd M, et al.. Acidity generated by the tumor microenvironment drives local invasion. Cancer Res. 2013, 73:1524-35. 10.1158\/0008-5472.CAN-12-2796","journal-title":"Cancer Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.24684","article-title":"Roles of GLUT-1 and HK-II expression in the biological behavior of head and neck cancer","volume":"10","author":"Yang H","year":"2019","unstructured":"Yang H, Zhong JT, Zhou SH, Han HM. Roles of GLUT-1 and HK-II expression in the biological behavior of head and neck cancer. Oncotarget. 2019, 10:3066-83. 10.18632\/oncotarget.24684","journal-title":"Oncotarget"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-113960","article-title":"PKM2 mediates chronic myeloid leukemia imatinib resistance by regulating glycolysis energy metabolism","volume":"132","author":"Tong L","year":"2018","unstructured":"Tong L, Xu N, Zhou X, et al.. PKM2 mediates chronic myeloid leukemia imatinib resistance by regulating glycolysis energy metabolism. Blood. 2018, 132:1724. 10.1182\/blood-2018-99-113960","journal-title":"Blood"},{"key":"ref22","unstructured":"The Warburg effect. tyrosine kinase signaling in leukemia cell metabolism. (2016). Accessed: April 17,2021: https:\/\/www.lls.org\/content\/the-warburg-effect-tyrosine-kinase-signaling-in-leukemia-cell-metabolism.."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2011.10.015","article-title":"Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolism","volume":"44","author":"Hitosugi T","year":"2011","unstructured":"Hitosugi T, Fan J, Chung TW, et al.. Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolism. Mol Cell. 2011, 44:864-77. 10.1016\/j.molcel.2011.10.015","journal-title":"Mol Cell"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2006.10.020","article-title":"A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth","volume":"11","author":"Bonnet S","year":"2007","unstructured":"Bonnet S, Archer SL, Allalunis-Turner J, et al.. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell. 2007, 11:37-51. 10.1016\/j.ccr.2006.10.020","journal-title":"Cancer Cell"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/1752-1947-9-16","article-title":"A case of type B lactic acidosis as a complication of chronic myelomonocytic leukaemia: a case report and review of the literature","volume":"9","author":"Gardner AJ","year":"2015","unstructured":"Gardner AJ, Griffiths J. A case of type B lactic acidosis as a complication of chronic myelomonocytic leukaemia: a case report and review of the literature. J Med Case Rep. 2015, 9:16. 10.1186\/1752-1947-9-16","journal-title":"J Med Case Rep"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.4103\/0973-1482.25858","article-title":"A typical presentation of acute myeloid leukemia","volume":"2","author":"Udayakumar N","year":"2006","unstructured":"Udayakumar N, Rajendiran C, Muthuselvan R. A typical presentation of acute myeloid leukemia. J Cancer Res Ther. 2006, 2:82-4. 10.4103\/0973-1482.25858","journal-title":"J Cancer Res Ther"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfg053","article-title":"Symptomatic lactic acidosis due to relapse of T-cell acute lymphoblastic leukaemia in the kidney","volume":"18","author":"De Keulenaer B","year":"2003","unstructured":"De Keulenaer B, Van Outryve S, De Backer A, et al.. Symptomatic lactic acidosis due to relapse of T-cell acute lymphoblastic leukaemia in the kidney. Nephrol Dial Transplant. 2003, 18:1214-6. 10.1093\/ndt\/gfg053","journal-title":"Nephrol Dial Transplant"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2010.33","article-title":"Metabolic acidosis: pathophysiology, diagnosis and management","volume":"6","author":"Kraut JA","year":"2010","unstructured":"Kraut JA, Madias NE. Metabolic acidosis: pathophysiology, diagnosis and management. Nat Rev Nephrol. 2010, 6:274-85. 10.1038\/nrneph.2010.33","journal-title":"Nat Rev Nephrol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1100\/tsw.2011.125","article-title":"Type B lactic acidosis secondary to malignancy: case report, review of published cases, insights into pathogenesis, and prospects for therapy","volume":"11","author":"Ruiz JP","year":"2011","unstructured":"Ruiz JP, Singh AK, Hart P. Type B lactic acidosis secondary to malignancy: case report, review of published cases, insights into pathogenesis, and prospects for therapy. ScientificWorldJournal. 2011, 11:1316-24. 10.1100\/tsw.2011.125","journal-title":"ScientificWorldJournal"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(73)90177-0","article-title":"Metabolic and therapeutic studies of a patient with acute leukemia and severe lactic acidosis of prolonged duration","volume":"55","author":"Wainer RA","year":"1973","unstructured":"Wainer RA, Wiernik PH, Thompson W. Metabolic and therapeutic studies of a patient with acute leukemia and severe lactic acidosis of prolonged duration. Am J Med. 1973, 55:255-260. 10.1016\/0002-9343(73)90177-0","journal-title":"Am J Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e318125759a","article-title":"Type B lactic acidosis as a severe metabolic complication in lymphoma and leukemia: a case series from a single institution and literature review","volume":"86","author":"Friedenberg AS","year":"2007","unstructured":"Friedenberg AS, Brandoff DE, Schiffman FJ. Type B lactic acidosis as a severe metabolic complication in lymphoma and leukemia: a case series from a single institution and literature review. Medicine (Baltimore). 2007, 86:225-32. 10.1097\/MD.0b013e318125759a","journal-title":"Medicine (Baltimore)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/68250-metabolic-acidosis-in-leukemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:28:34Z","timestamp":1707506914000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/68250-metabolic-acidosis-in-leukemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,5]]},"references-count":31,"URL":"https:\/\/doi.org\/10.7759\/cureus.17732","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,5]]}}}